Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587751 · ClinicalTrials.gov registry record · NA
Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients
A NA study of Hormonal Gender-Affirming Therapy, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT05587751 is a NA study of Hormonal Gender-Affirming Therapy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 44 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05587751, a NA study of Hormonal Gender-Affirming Therapy, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate whether undergoing gender affirming care will impact the way the lungs function.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Spirometry
- DIAGNOSTIC_TEST Plethysmography
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05587751
The ClinicalTrials.gov registry entry for NCT05587751 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hormonal Gender-Affirming Therapy appearing as the primary indexed condition, and to 2 interventions - of which Spirometry is the first listed.
NCT05587751 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05587751 about?
NCT05587751 is a clinical study titled "Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients". The purpose of this research study is to evaluate whether undergoing gender affirming care will impact the way the lungs function.
What is the current status of trial NCT05587751?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-02-01. Estimated completion is 2027-07.
What conditions does trial NCT05587751 study?
This clinical trial studies the following conditions: Hormonal Gender-Affirming Therapy.
What interventions are being tested in trial NCT05587751?
The interventions under investigation include: Spirometry (DIAGNOSTIC_TEST), Plethysmography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05587751?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587751 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.